| Product Code: ETC12838539 | Publication Date: Apr 2025 | Updated Date: Feb 2026 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sachin Kumar Rai | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
In 2024, Germany`s influenza medications market saw a notable increase in imports. The trend reflected a growing demand for foreign pharmaceutical products within the country`s market.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Germany Influenza Medications Market Overview |
3.1 Germany Country Macro Economic Indicators |
3.2 Germany Influenza Medications Market Revenues & Volume, 2022 & 2032F |
3.3 Germany Influenza Medications Market - Industry Life Cycle |
3.4 Germany Influenza Medications Market - Porter's Five Forces |
3.5 Germany Influenza Medications Market Revenues & Volume Share, By Drug Type, 2022 & 2032F |
3.6 Germany Influenza Medications Market Revenues & Volume Share, By Route of Administration, 2022 & 2032F |
3.7 Germany Influenza Medications Market Revenues & Volume Share, By Patient Age Group, 2022 & 2032F |
4 Germany Influenza Medications Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of influenza in Germany |
4.2.2 Growing awareness about the importance of vaccination |
4.2.3 Technological advancements in influenza medication development |
4.3 Market Restraints |
4.3.1 Seasonal nature of influenza outbreaks |
4.3.2 High competition among pharmaceutical companies |
4.3.3 Regulatory challenges in drug approval process |
5 Germany Influenza Medications Market Trends |
6 Germany Influenza Medications Market, By Types |
6.1 Germany Influenza Medications Market, By Drug Type |
6.1.1 Overview and Analysis |
6.1.2 Germany Influenza Medications Market Revenues & Volume, By Drug Type, 2022 - 2032F |
6.1.3 Germany Influenza Medications Market Revenues & Volume, By Antiviral Drugs (Oseltamivir, Zanamivir, Peramivir, Baloxavir), 2022 - 2032F |
6.1.4 Germany Influenza Medications Market Revenues & Volume, By Symptom Relief Medications (Pain Relievers, Decongestants, Antihistamines), 2022 - 2032F |
6.2 Germany Influenza Medications Market, By Route of Administration |
6.2.1 Overview and Analysis |
6.2.2 Germany Influenza Medications Market Revenues & Volume, By Oral, 2022 - 2032F |
6.2.3 Germany Influenza Medications Market Revenues & Volume, By Intravenous (IV), 2022 - 2032F |
6.2.4 Germany Influenza Medications Market Revenues & Volume, By Inhalation, 2022 - 2032F |
6.3 Germany Influenza Medications Market, By Patient Age Group |
6.3.1 Overview and Analysis |
6.3.2 Germany Influenza Medications Market Revenues & Volume, By Pediatric, 2022 - 2032F |
6.3.3 Germany Influenza Medications Market Revenues & Volume, By Adult, 2022 - 2032F |
6.3.4 Germany Influenza Medications Market Revenues & Volume, By Geriatric, 2022 - 2032F |
7 Germany Influenza Medications Market Import-Export Trade Statistics |
7.1 Germany Influenza Medications Market Export to Major Countries |
7.2 Germany Influenza Medications Market Imports from Major Countries |
8 Germany Influenza Medications Market Key Performance Indicators |
8.1 Number of influenza cases reported annually in Germany |
8.2 Percentage of population vaccinated against influenza |
8.3 Research and development investment in new influenza medications |
9 Germany Influenza Medications Market - Opportunity Assessment |
9.1 Germany Influenza Medications Market Opportunity Assessment, By Drug Type, 2022 & 2032F |
9.2 Germany Influenza Medications Market Opportunity Assessment, By Route of Administration, 2022 & 2032F |
9.3 Germany Influenza Medications Market Opportunity Assessment, By Patient Age Group, 2022 & 2032F |
10 Germany Influenza Medications Market - Competitive Landscape |
10.1 Germany Influenza Medications Market Revenue Share, By Companies, 2025 |
10.2 Germany Influenza Medications Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here